Role of catecholamines in the central effects of amphetamine.
D000661:Amphetamine / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry; D002395:Catecholamines / Q000032:analysis*; D004298:Dopamine / Q000032:analysis; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis; D010101:Oxygen Consumption / Q000187:drug effects; D011299:Prenylamine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012640:Seizures / Q000453:epidemiology
D002395:Catecholamines; D008781:Methyltyrosines; D012110:Reserpine; D000661:Amphetamine; D011299:Prenylamine; D004298:Dopamine; D009638:Norepinephrine; D006145:Guanethidine